| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0140-6736(90)92082-S |
| P698 | PubMed publication ID | 1975036 |
| P2093 | author name string | H Bismuth | |
| D Samuel | |||
| M Reynes | |||
| J Gugenheim | |||
| P433 | issue | 8714 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver transplantation | Q1368191 |
| P304 | page(s) | 519-523 | |
| P577 | publication date | 1990-09-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Liver transplantation across ABO blood group barriers | |
| P478 | volume | 336 |
| Q34206939 | A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies |
| Q41960411 | A modified protocol with rituximab and intravenous immunoglobulin in emergent ABO-incompatible liver transplantation for acute liver failure |
| Q47752841 | A simplified protocol using rituximab and immunoglobulin for ABO-incompatible low-titre living donor liver transplantation |
| Q37367628 | ABO incompatible liver transplantation as a bridge to treat HELLP syndrome |
| Q38422411 | ABO-Incompatible Adult Living Donor Liver Transplantation Under the Desensitization Protocol With Rituximab. |
| Q91725102 | ABO-Incompatible Adult Living Donor Liver Transplantation in the Era of Rituximab: A Systematic Review and Meta-Analysis |
| Q46311043 | ABO-incompatible adult living donor liver transplantation for hepatocellular carcinoma |
| Q90705931 | ABO-incompatible deceased donor pediatric liver transplantation: Novel titer-based management protocol and outcomes |
| Q41516975 | ABO-incompatible liver transplantation for severe hepatitis B patients |
| Q51037308 | ABO-incompatible liver transplantation in acute liver failure: a single Portuguese center study. |
| Q34156791 | ABO-incompatible living donor liver transplantation without graft local infusion and splenectomy. |
| Q77632803 | ABO-incompatible living related liver transplantation for fulminant hepatitis: report of a successful pediatric case with long-term follow-up |
| Q35116720 | ABO-incompatible organ and bone marrow transplantation: current status |
| Q37984656 | ABO-incompatible organ transplantation. |
| Q40736164 | Absorption of anti-blood group A antibodies on P-selectin glycoprotein ligand-1/immunoglobulin chimeras carrying blood group A determinants: core saccharide chain specificity of the Se and H gene encoded alpha1,2 fucosyltransferases in different hos |
| Q50736795 | Adult ABO-incompatible liver transplantation, using A and B donors. |
| Q41845634 | Adult Living Donor Liver Transplantation with ABO-Incompatible Grafts: A German Single Center Experience |
| Q51016759 | Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch. |
| Q71900577 | Auxiliary partial orthotopic liver transplantation for fulminant hepatitis. The Paul Brousse experience |
| Q37782255 | B cells and transplantation tolerance |
| Q40741639 | Chemotherapy-induced B-cell depletion in hepatoblastoma patients undergoing ABO-incompatible living donor liver transplantation |
| Q50906423 | Chronic antibody-mediated responses may mediate chronic rejection in rat orthotopic liver transplantation. |
| Q90523525 | Comparison of Liver Graft Regeneration Between ABO-Compatible and ABO-Incompatible Living Donor Liver Transplantation: A Propensity Score Matching Analysis |
| Q67586758 | Current experience with renal transplantation across the ABO barrier |
| Q28077320 | Current techniques for AB0-incompatible living donor liver transplantation |
| Q70670258 | Diagnostic features and clinical outcome of ischemic-type biliary complications after liver transplantation |
| Q67586757 | Diffuse biliary tract injury after orthotopic liver transplantation |
| Q33178979 | Does the donor-recipient ABO blood group compatibility status predict subsequent lung transplantation outcomes? |
| Q34361643 | Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation |
| Q84969557 | Early detection of biliary complications and graft rejection in a non-RH Identitical liver transplant recipient from a non-heart-beating donor: a case report |
| Q74348237 | Effect of ABO blood type matching in cardiac transplant recipients |
| Q38029570 | Emergency ABO-incompatible liver transplant secondary to fulminant hepatic failure: outcome, role of TPE and review of the literature |
| Q50531619 | End-stage liver cirrhosis with severe autoimmune hemolytic anemia, treated by blood type-incompatible living donor liver transplantation: a case report. |
| Q36790927 | Experiences of 120 microsurgical reconstructions of hepatic artery in living related liver transplantation |
| Q38642534 | Extracorporeal photopheresis and liver transplantation: Our experience and preliminary data |
| Q53545383 | Follow-up after liver transplantation for primary sclerosing cholangitis: effects on survival, quality of life, and colitis. |
| Q26822887 | From immunosuppression to tolerance |
| Q38181847 | Graft cholangiopathy: etiology, diagnosis, and therapeutic strategies |
| Q47340803 | Graft size-matching in living related partial liver transplantation in relation to tissue oxygenation and metabolic capacity |
| Q37780069 | Histological findings in liver allograft rejection--new insights into the pathogenesis of hepatocellular damage in liver allografts |
| Q42059920 | How valid is emergency liver transplantation for acute liver necrosis in patients with multiple-organ failure? |
| Q36966364 | Human hepatic stellate cells inhibit T-cell response through B7-H1 pathway |
| Q95654106 | Imaging Diagnosis of Biliary Complications of ABO Incompatibility in Living Donor Liver Transplantation |
| Q38478624 | Imaging of biliary complications in recipients of right-lobe living donor liver transplantation |
| Q92606381 | Immunologic strategies and outcomes in ABO-incompatible living donor liver transplantation |
| Q26766049 | Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients |
| Q72316288 | Inappropriate expression of blood group antigens in hepatic allografts |
| Q34351946 | Increased bile duct complications in liver transplantation across the ABO barrier |
| Q45163956 | Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice |
| Q46500091 | Internal bioartificial liver with xenogeneic hepatocytes prevents death from acute liver failure: an experimental study |
| Q37844420 | Interventional radiology: management of biliary complications of liver transplantation |
| Q34210636 | Intrahepatic cholestasis following liver transplantation |
| Q35715908 | Intravenous immunoglobulins in liver transplant patients: Perspectives of clinical immune modulation |
| Q35864132 | Ischemia-Reperfusion Injury and Ischemic-Type Biliary Lesions following Liver Transplantation |
| Q68184067 | Ischemic-type biliary complications after orthotopic liver transplantation |
| Q72511402 | Ischemic-type biliary strictures in liver allografts: the Achilles heel revisited? |
| Q53248278 | Kinetics of B, T, NK lymphocytes and isoagglutinin titers in ABO incompatible living donor liver transplantation using rituximab and basiliximab. |
| Q37435542 | Laboratory monitoring of nonrenal allograft rejection. |
| Q52956160 | Liver transplantation across ABO blood groups. |
| Q35751557 | Liver transplantation across Rh blood group barriers increases the risk of biliary complications |
| Q74571040 | Liver transplantation across the ABO barrier: the role of plasmapheresis |
| Q41016665 | Liver transplantation. The last ten years. |
| Q46106647 | Liver transplantation: Evading antigens-ABO-incompatible liver transplantation |
| Q77632796 | Living related liver transplantation in patients with ABO incompatibility |
| Q73304745 | Long-term follow-up (more than 5 years) of patients after living-related liver transplantation |
| Q37848741 | Management of ABO-incompatible living-donor liver transplantation: past and present trends |
| Q38172280 | Molecular deciphering of the ABO system as a basis for novel diagnostics and therapeutics in ABO incompatible transplantation |
| Q40734456 | Natural anti-carbohydrate IgM in mice: dependence on age and strain |
| Q74252400 | Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study |
| Q40976880 | Orthotopic Liver Transplantation in Fulminant and Subfulminant Hepatitis The Paul Brousse Experience |
| Q44925956 | Outcomes after identical and compatible orthotopic liver transplantation for fulminant hepatic failure: a single center experience in UK. |
| Q42695184 | Outcomes after liver transplantation in accordance with ABO compatibility: A systematic review and meta-analysis |
| Q81422881 | Present status of ABO-incompatible living donor liver transplantation in Japan |
| Q34280929 | Pretransplant assessment of human liver grafts by plasma lecithin: cholesterol acyltransferase (LCAT) activity in multiple organ donors |
| Q50484739 | Production of anti-ABO blood group antibodies after minor ABO-incompatible bone marrow transplantation in NOD/SCID/gamma(c)(null) mice. |
| Q33808643 | Recipient outcomes after ABO-incompatible liver transplantation: a systematic review and meta-analysis |
| Q67469969 | Role of the ABO system in transplants and grafts |
| Q35195451 | Safety and efficacy of endoscopic retrograde cholangiopancreatography in patients with post-liver transplant biliary complications: results of a cohort study with long-term follow-up |
| Q53868277 | Strategic breakthrough in adult ABO-incompatible living donor liver transplantation: preliminary results of consecutive seven cases. |
| Q50715244 | Successful ABO-incompatible liver transplantation using A2 donors. |
| Q38453652 | Successful experiences of ABO-incompatible adult living donor liver transplantation in a single institute: no immunological failure in 10 consecutive cases |
| Q36453901 | Surgical emergencies in liver disease |
| Q95380179 | The pathological characteristics of acute antibody-mediated rejection in DA-to-Lewis rat orthotopic liver transplantation |
| Q85642885 | The reduction rate of serum C3 following liver transplantation is an effective predictor of non-anastomotic strictures |
| Q79439021 | The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation |
| Q28536567 | The transcriptomic response of rat hepatic stellate cells to endotoxin: implications for hepatic inflammation and immune regulation |
| Q46924230 | Use of ABO-incompatible grafts in living donor liver transplantation--first report from India |
| Q77059961 | What is the significance of acute liver allograft rejection? |
| Q41696788 | What should we expect from a bioartificial liver in fulminant hepatic failure? |
| Q34170336 | Xenotransplantation of the liver |
| Q72033847 | [Immuno-hematologic aspects of xenotransplantation] |
Search more.